USPTO serial 90508270
ATRECA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JACKSON, SHA-KARA ELOUISE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ATRECA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Carlos, CA
San Carlos, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
R. Gwen Peterson
R. Gwen Peterson Kilpatrick Townsend & Stockton LLP2175 North California BoulevardSuite 600Walnut Creek, CA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for clinical use and scientific research; biological tissue cultures for clinical use and scientific research; antibodies for clinical use and scientific research; combinations of biological tissue cultures for clinical use and scientific research; and combinations of antibodies for clinical use and scientific research | ACTIVE | — |
| 005 | Biologics for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, biologics and antibodies for the treatment of oncological, infectious disease, and immune system related diseases, disorders and conditions; diagnostic agents, preparations and substances for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations, biologics and antibodies for medical purposes, namely, for detecting the presence of malignant, inflammatory, infectious and autoimmune diseases, disorders and conditions in humans | ACTIVE | — |
| 042 | Biological and pharmaceutical research and development; research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of such diagnostics and biologics; molecular biology research for diagnostic preparations, biologics, combinations of diagnostic preparations and biologics, and diagnostic kits for scientific research use; scientific research in the field of cancer and infectious disease treatment and diagnosis; providing laboratory research services in the field of cancer biology and infectious disease biology; testing, inspection, research and development of pharmaceutical preparations for cancer and infectious diseases; providing laboratory research services in the field of cancer biology and infectious diseases; research and development services in the field of antibodies; providing medical and scientific research information in the fields of cancer research, infectious disease research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Atreca, Inc.
- Other trademarks owned by Atreca, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ATRECA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 24, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 7, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 5, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 5, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 5, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 5, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 3, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 3, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 3, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 5, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 3, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 3, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 3, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 13, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 11, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 11, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 11, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 23, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 28, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 28, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 8, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 27, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 27, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 27, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2021 | NWAP | NEW APPLICATION ENTERED | — |